乳腺细胞作为动脉动脉生成的关键参与者. 审查 审查 审查 审查
Jacek Jawień1, Magdalena Bartuś2
1Department of Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland. jacek.jawien@uj.edu.pl.
Folia medica Cracoviensia
|October 8, 2025
概括
乳腺细胞,关键的免疫细胞,显著促进动脉样硬化发展. 它们的介质促进血管壁的变化,影响心血管疾病.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管科学 心血管科学
- 病理学 病理学 病理学
背景情况:
- 乳腺细胞是关键的免疫细胞,参与宿主防御和亚托皮性疾病.
- 新出现的证据凸显了巨细胞在动脉样硬化发展中的重要作用.
- 激活的巨细胞释放介质,可以在血管壁内促进益动原性作用.
研究的目的:
- 审查当前对乳腺生成中巨细胞功能的理解.
- 讨论巨细胞在动脉样硬化相关心血管疾病中的参与.
主要方法:
- 关于巨细胞和动脉样硬化的现有研究的文献综述.
- 综合当前关于巨细胞媒介体的知识及其对血管病理学的影响.
主要成果:
- 乳腺细胞通过介质释放促进了多个阶段的动脉生成.
- 特定的杆细胞媒介被确定为促进动脉样硬化斑块形成和进展的关键参与者.
结论:
- 乳腺细胞是动脉样硬化病原体的组成部分.
- 向巨细胞活动为心血管疾病提供了潜在的治疗策略.
相关概念视频
Inflammation
46.6K
Overview
46.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112


